SLVM (Sylvamo Corporation) Stock Analysis - Hedge Fund Holdings
Sylvamo Corporation (SLVM) is a publicly traded Basic Materials sector company. As of May 21, 2026, SLVM trades at $37.24 with a market cap of $1.48B and a P/E ratio of 14.59. SLVM moved +4.75% today. Year to date, SLVM is -22.07%; over the trailing twelve months it is -35.18%. Its 52-week range spans $35.53 to $98.02. Analyst consensus is buy with an average price target of $51.50. Rallies surfaces SLVM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns SLVM stock?
Hedge funds tracked by Rallies that own SLVM include Rokos Capital, Eisler Capital, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sylvamo Corporation.
SLVM Key Metrics
Key financial metrics for SLVM
Metric
Value
Price
$37.24
Market Cap
$1.48B
P/E Ratio
14.59
EPS
$2.56
Dividend Yield
0.45%
52-Week High
$98.02
52-Week Low
$35.53
Volume
2
Avg Volume
0
Revenue (TTM)
$3.29B
Net Income
$102.00M
Gross Margin
0.00%
Top Hedge Funds Holding SLVM
Rokos Capital holds 255.67K shares of SLVM, changed +0.00% as of Mar 31, 2026.
Eisler Capital holds 12.05K shares of SLVM, changed +0.00% as of Jun 30, 2024.
Pinebridge Investments holds 560 shares of SLVM, changed +0.00% as of Jun 30, 2023.
Hedge funds tracked by Rallies that own SLVM include Rokos Capital, Eisler Capital, and Pinebridge Investments. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sylvamo Corporation.
Does Rallies show 13F holders for SLVM?
Yes. Rallies tracks hedge fund and 13F ownership data for SLVM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SLVM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for SLVM. It does not provide personalized investment advice.